234 related articles for article (PubMed ID: 22705252)
1. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.
Hazelton WD; Goodman G; Rom WN; Tockman M; Thornquist M; Moolgavkar S; Weissfeld JL; Feng Z
Math Biosci; 2012 Nov; 240(1):20-34. PubMed ID: 22705252
[TBL] [Abstract][Full Text] [Related]
2. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.
Diederich S; Thomas M; Semik M; Lenzen H; Roos N; Weber A; Heindel W; Wormanns D
Eur Radiol; 2004 Apr; 14(4):691-702. PubMed ID: 14727146
[TBL] [Abstract][Full Text] [Related]
3. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
[TBL] [Abstract][Full Text] [Related]
4. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.
Schabath MB; Massion PP; Thompson ZJ; Eschrich SA; Balagurunathan Y; Goldof D; Aberle DR; Gillies RJ
PLoS One; 2016; 11(8):e0159880. PubMed ID: 27509046
[TBL] [Abstract][Full Text] [Related]
5. CT scan screening for lung cancer: risk factors for nodules and malignancy in a high-risk urban cohort.
Greenberg AK; Lu F; Goldberg JD; Eylers E; Tsay JC; Yie TA; Naidich D; McGuinness G; Pass H; Tchou-Wong KM; Addrizzo-Harris D; Chachoua A; Crawford B; Rom WN
PLoS One; 2012; 7(7):e39403. PubMed ID: 22768300
[TBL] [Abstract][Full Text] [Related]
6. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements.
Goodman GE; Thornquist MD; Balmes J; Cullen MR; Meyskens FL; Omenn GS; Valanis B; Williams JH
J Natl Cancer Inst; 2004 Dec; 96(23):1743-50. PubMed ID: 15572756
[TBL] [Abstract][Full Text] [Related]
7. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis.
Rampinelli C; De Marco P; Origgi D; Maisonneuve P; Casiraghi M; Veronesi G; Spaggiari L; Bellomi M
BMJ; 2017 Feb; 356():j347. PubMed ID: 28179230
[No Abstract] [Full Text] [Related]
8. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
9. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
[TBL] [Abstract][Full Text] [Related]
11. Small median tumor diameter at cure threshold (<20 mm) among aggressive non-small cell lung cancers in male smokers predicts both chest X-ray and CT screening outcomes in a novel simulation framework.
Goldwasser DL; Kimmel M
Int J Cancer; 2013 Jan; 132(1):189-97. PubMed ID: 22510979
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
13. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
[TBL] [Abstract][Full Text] [Related]
15. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
[TBL] [Abstract][Full Text] [Related]
16. Lung cancer screening with spiral CT: baseline results of the randomized DANTE trial.
Infante M; Lutman FR; Cavuto S; Brambilla G; Chiesa G; Passera E; Angeli E; Chiarenza M; Aranzulla G; Cariboni U; Alloisio M; Incarbone M; Testori A; Destro A; Cappuzzo F; Roncalli M; Santoro A; Ravasi G;
Lung Cancer; 2008 Mar; 59(3):355-63. PubMed ID: 17936405
[TBL] [Abstract][Full Text] [Related]
17. Performance of Risk Factor-Based Guidelines and Model-Based Chest CT Lung Cancer Screening in World Trade Center-Exposed Fire Department Rescue/Recovery Workers.
Cleven KL; Vaeth B; Zeig-Owens R; Colbeth HL; Jaber N; Schwartz T; Weiden MD; Markowitz SB; Silvestri GA; Prezant DJ
Chest; 2021 May; 159(5):2060-2071. PubMed ID: 33279511
[TBL] [Abstract][Full Text] [Related]
18. Mortality outcomes of low-dose computed tomography screening for lung cancer in urban China: a decision analysis and implications for practice.
Wang Z; Han W; Zhang W; Xue F; Wang Y; Hu Y; Wang L; Zhou C; Huang Y; Zhao S; Song W; Sui X; Shi R; Jiang J
Chin J Cancer; 2017 Jul; 36(1):57. PubMed ID: 28709441
[TBL] [Abstract][Full Text] [Related]
19. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results.
Pastorino U; Bellomi M; Landoni C; De Fiori E; Arnaldi P; Picchio M; Pelosi G; Boyle P; Fazio F
Lancet; 2003 Aug; 362(9384):593-7. PubMed ID: 12944057
[TBL] [Abstract][Full Text] [Related]
20. Assessment of lung-cancer mortality reduction from CT Screening.
Henschke CI; Boffetta P; Gorlova O; Yip R; Delancey JO; Foy M
Lung Cancer; 2011 Mar; 71(3):328-32. PubMed ID: 21168236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
